Equity Pharmaceuticals

Equity Section 21 specialises in the import and supply of unlicensed medicine into South Africa.

We are able to give physicians in South Africa a treatment option (final pricing, lead-time, application process etc.) within 24 hours.

We currently import and supply around 450 different products on Managed Access or Global Access Programs.

We keep our top 150 unlicensed products on hand in our warehouse to ensure we are able to assist patients immediately.

We have build up a large network of suppliers/wholesalers around the world and are the market leaders in UL Supply in South Africa since 2009.